Expert Briefings

Welcome to the Expert Briefings section of our Research Hub! Here, we present invaluable insights and comprehensive analyses from top health policy experts, all of whom have shared their expertise at our annual Lifecourse Summit Meetings. These briefings span a diverse range of topics, each one carefully crafted to provide you with the latest evidence-based information crucial for informed policy-making. Whether you are developing new strategies or refining existing approaches, these resources are designed to arm you with the knowledge and perspectives essential for advancing healthcare outcomes across Europe. Dive into our content and let the expert insights from our Lifecourse Summit Meetings inspire your path towards innovative and effective health policy development.

Adults 65+ in a Lifecourse Approach to Immunisation

Jean-Pierre Michel, Geneva University Medical School, Switzerland and Jane Barratt, at International Federation on Ageing (IFA)

RSV and Shingles Vaccines in Adults

Jean-Pierre Michel Head of the Geriatric Ward at Geneva University Medical School, Switzerland

RSV All Infant Immunisation Implementation in Spain

Jaime Perez Martin at Murcia Health Council (Spain)

Parent Stories For RSV - The Need for Better Awareness and Prevention

Lies Kriek at ReSViNET Foundation

Easing the Burden of RSV- Implementing Immunisation Programs

George Valiotis European Health Management Association (EHMA)

Antibody Levels and Duration of Protection Against RSV with Different Strategies

Maternal Vaccination As A Lifecourse Appproach

RSV In Young Infants- New Paths for Immunisation

Catherine Weil-Olivier (University Paris 7)

Communicating The Burden Of RSV To Policymakers

The How And Why To Protect Older People Against RSV Infections

The Global RSV Vaccine And mAb Landscape

Jonne Terstappen, Center of Translational Immunology, Wilhelmina Children's Hospital (part of UMC Utrecht) (NL)

Strategies To Counter Limited Knowledge And Awareness Of RSV Infections

George Valiotis European Health Management Association (EHMA)

RSV: Perspectives To Strengthen The Need For Protection On All Infants

Catherine Weil-Olivier (University Paris 7)

RSV - Prospective Immunization

Shifting The Paradigm In RSV Prevention: Lessons From Emerging Threats And Global Health Security

Impact on families: A Parent's Story of RSV

Evidence-Based Preventive Approaches For RSV-Associated Acute Lower Respiratory Infections (ALPI) In Infants

The Hidden Burden - High Frequency Of Viral Co-Detections In Acute Bronchiolitis

The Burden Of RSV In Healthy Children

RSV Surveillance In The Netherlands And In Europe

How Well Aware Are We Of The Epidemiology Of RSV Infections In The Community?

George Syrogiannopoulos (University of Thessaly)

Increasing Vaccine Confidence In Older At-Risk Population

The Crucial Role Nurses Can Play In Increasing Vaccine Confidence

Elizabeth Adams at European Federation of Nurse Associations

The Role Of Civil Society In Promoting Vaccination Across The Life Course

Daniela Quaggia, Active Citizenship Network (ACN) (IT)

Why Public Demand Is Important For A Successful Life Course Immunisation

Identifying Factors Driving Vaccination Uptake Amongst Healthcare Workers

Fighting Online Misinformation In The Post-COVID Era

Gary Finnegan at Vaccines Today

The Importance Of Social Networks And Platforms To Vaccine Confidence

Lessons From One Of The Largest Immunisation Programs In The World

Ramesh Kumar, President Indian Academy of Pediatrics (IPA)

Building Older Adult Immunisation Programs

Strengthening Adolescents Immunisation Programs In Europe

Maternal Vaccinations: Building Trust Among Pregnant Women

Harmonising Guidelines For Adequate Immunisation Of Adult Immunocompromised Patients

LifeCourse Vaccinations Role In Reducing Hospital Admissions And Burden

Carlo Signorelli, Vita-Salute San Raffaele, Milan (IT)

Immunisation Across The LifeCourse Resulting In Population-Wide Health Benefits

Catherine Weil-Olivier (University Paris 7)

Examining Disruptions To Routine Childhood Vaccinations During The COVID-19 Pandemic

The Global Roadmap To Defeat Meningitis – Can We Eradicate Meningococcal Disease?

Meningococcal Disease And Meningitis Vaccinations – What Are The Remaining Barriers?

Increasing Influenza Vaccinations Rates In All Age Groups Across Europe

Evidence Exploring Antibody Levels And Duration Of Protection Against RSV With Different Strategies

Prevention Of Pediatric Influenza. How Do We Get There?

Lessons From Previous Influenza Seasons

RSV Disease Burden In The Hospital Setting And The Impact On Healthcare Resources

RSV Bronchiolitis: Present and Future

Analysing The Impact Of RSV In The Healthcare Setting

RSV Disease Burden In Private Practice And The Wider Impact On Healthcare Resources

Exploring HPV Vaccines And COVID Vaccines In Relation To Adolescents

How Can We Establish The Importance Of Protecting Against Meningococcal Strains To All Types And Populations?

How COVID has Changed Vaccine Attitudes

How can we make the most of existing flu vaccines to provide the best protection for the elderly population?

What Options Do We Have In Terms Of Altered Approach To Influenza Vaccination?

Will Pressure On The Public To Vaccinate Against COVID Offers An Opportunity To Establish All Vaccinations As Socially Responsible Behaviour?

Markers For COVID19 Vaccine Acceptance/Refusal In Young Children

COVID Vaccine In The Age Of Personalised Medicine - A New Brand Of Vaccine Hesitancy

How Can We Increase Awareness On The Importance Of Meningococcal Vaccinations Once Again?

Nenad Miljković at European Association of Hospital Pharmacists (EAHP)

Measuring Vaccine Confidence On Twitter

Should Obligatory Vaccination Against COVID For HCPs, Pave The Way For Similar Interventions For Other Vaccines?

How Can We Build On Our Covid Experience And Move To A Lifecourse Immunisation Approach?

Update On Implemented PPV23 Vaccination For The Elderly In The Netherlands

Mirjam Knol, at Center of Infectious Disease Control (RIVM)

Co-production With Young People An Educational Resource For Delivery In Schools

How Can We React To The Dynamic Shifts in the Three Main Social Groups; the Believers, the Indifferent, and Those Against Vaccines?

The Control Of Meningococcal Disease - The Impact Of COVID-19

How Can We Make Health Systems More Resilient To COVID-19 And Other Crises?

Shifting the Paradigm: Using Disease Outbreaks To Build Resilient Health Systems

Meningococcal Disease And Meningococcal Vaccination In Times Of The COVID-19 Pandemic

Mirjam Knol, at Center of Infectious Disease Control (RIVM)

COVID Vaccine Update - Can And Should Influenza Vaccines Be Delivered At The Same Time As A COVID-19 Vaccine?

Reviewing The Rise Of Online Misinformation, Fuelled By The Increased Interest From COVID-19

Gary Finnegan at Vaccines Today

Examining Interactions Between Seasonal Influenza And COVID-19 And The Practicalities Of COVID And Flu Vaccines Together

Paolo Bonani at University of Florence, ITALY

The COVID Equation - Understanding And Communicating LifeCourse Vaccinations' Role In The Reduction Of Hospitalisations, Ambulatory Care Visits, And Medical Interventions

The Role Of Vaccination Across The LifeCourse In The Sustainability Of Healthcare Systems

Lessons Learned From Previous Influenza Seasons To Enhance Vaccine Uptake In The Epidemic.

Parental Perception Of Influenza And Flu Vaccinations In Romania - Reviewing The Latest Results From 13,000 Survey Responses

The Infection That Could Be More Deadly For Students Than Coronavirus: How Self-Isolating Students Could Mistake Meningitis Symptoms For COVID-19

The Global Roadmap To Defeat Meningitis By 2030 - What's Next?

The Importance Of Education About Vaccination And Vaccine Hesitancy Amongst HCPs